Showing 2241-2250 of 18609 results for "".
Identifying Unmet Needs in the Management of Glomerular Diseases
https://reachmd.com/programs/clinicians-roundtable/identifying-unmet-needs-in-the-management-of-glomerular-diseases/14906/Are you facing challenges when managing patients with glomerular diseases like IgA nephropathy and C3 glomerulopathy? If so, you’re not alone.Do Celebrity Heart Attacks Influence Public Health?
https://reachmd.com/programs/lipid-luminations/do-celebrity-heart-attacks-influence-public-health/3569/Celebrities, often criticized for their dubious influence on the public, may inadvertently promote good health when a famous celebrity dies from a heart attack. Dr. James Erhlich discusses how the sudden death of a famous person heightens the general population’s interest in cardiovascuManagement Issues in Familial Hypercholesterolemia
https://reachmd.com/programs/lipid-luminations/management-issues-in-familial-hypercholesterolemia/6480/Host Dr. Alan Brown discusses management issues and practical advice with certified registered nurse practitioner and clinical lipid specialist Joyce Ross, who says that familial hypercholesterolemia (FH) is the most common genetic disorder, and many who have it are totally unaware of their conditiHow to Use Medical Education as a Tool for Practice Quality Improvement
https://reachmd.com/programs/lifelong-learning/how-to-use-medical-education-as-a-tool-for-practice-quality-improvement/7159/"Quality improvement is not an event or a project; it's a continuous process." This is the sentiment of special guest Louis Diamond, President of the Quality in Health Care Advisory Group, LLC. Mr. Diamond also serves as Quality Improvement Education Initiation Chair for ACEHP. He joins host AliciaEmerging Insights into the Immunologic Subtypes of Atopic Dermatitis in Children
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37157/Robert Sidbury, MD, MPH, Chief of Dermatology at Seattle Children’s Hospital and Professor in the University of Washington Department of Pediatrics, discusses new understandings regarding the immunologic subtypes of atopic dermatitis and how they should influence treatment selection.Assessing the AMA MAP™ Hypertension Program’s Impact at Rush University Medical Center
https://reachmd.com/programs/perspectives-ama/assessing-the-ama-map-hypertension-programs-impact-at-rush-university-medical-center/26591/Hear about a clinician’s experience implementing the AMA MAP™ Hypertension quality improvement program at Rush University Medical Center.SCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. James Q. Del Rosso on Innovative Therapies
https://practicaldermatology.com/error/404/James Q. Del Rosso, DO, joins Joel Cohen, MD, to discuss innovation in the world of acne and rosacea, atopic dermatitis, psoriasis, alopecia areata, hidradenitis suppurativa, vitiligo, and more at Music City SCALE.Managing Internal Medicine Issues in Hospitalized Neurological Patients
https://reachmd.com/programs/neurofrontiers/primary-neurologically-hospitalized-patient-internal-medicine-issues/24169/What internal medicine complications are common in a neurologic hospitalized patient? Find out more.A Look at What’s New in Invasive Lobular Carcinoma
https://reachmd.com/programs/project-oncology/a-look-at-whats-new-in-invasive-lobular-carcinoma/16355/Invasive lobular carcinoma is a subtype of breast cancer that is difficult to diagnose. Learn more here.Tolerability of JAK Inhibitors Used in Dermatology
https://practicaldermatology.com/series/jak-inhibitors-in-practice/tolerability-of-jak-inhibitors-used-in-dermatology/20126/Although safety and tolerability are often intertwined, they are distinct considerations. Topical and oral JAKs used in dermatology today seem to offer good tolerability. Adelaide A. Hebert, MD and Matthew Zirwas, MD discuss potential side effects, management, and monitoring in pediatric and adult p